"Votrient": price, analogues. How much cheaper to buy "Votrient"?
In the therapy of renal cell carcinoma and soft tissue sarcoma, the drug "Votrient" proved to be very successful. This drug, suppressing thyroxine kinase - an enzyme responsible for the growth of blood vessels. As a result, malignant neoplasm of soft tissues does not expand, the tumor does not progress.
The active ingredient "Votrient" is pazopanib hydrochloride. Auxiliary components are magnesium stearate, sodium carboxymethyl starch, povidone K30 and microcrystalline cellulose.
Generic Votrient - what is this?
The original product is manufactured in the UK and Spain, and its cost ranges from 60 to 80 thousand rubles, if it is a question of packing tablets( 60 pieces) with a dosage of 200 mg, or 80 to 120 thousand, if it's 60 tablets, eachof which 400 mg of the main component. This variation in price is explained by the difference in prices in the pharmacies of Moscow and Russian regions. Still, the amount of even 60 000 rubles for many is palpable or practically impossible.
However, you can buy
Where to buy "Votrient" at a price that does not shock?
In order to purchase a generic, you will not need to look for a drug in the pharmacy chains of the city. You do not even need to go to the pharmacy. You can purchase the medication on the website of an Indian company with five years of successful experience
The condition for the provision of services is the availability of appropriate documents that can confirm the need for modern treatment.
How to use the product: dosage
Before using VOCENTENT, consult your doctor. The recommended dosage of the drug is 800 mg per day at one time. At the same time, try not to damage the outer shell of the tablet, that is, it is forbidden to crack or break it.
"Votrient" should be used approximately at the same time. If you missed the next appointment and left less than 12 hours to the next, then the missed dose is not recommended to be filled.
"Votrient" is contraindicated in the following categories of patients:
- having a severe degree of hepatic or renal insufficiency;
- for pregnant women and nursing mothers;
- for children under 2 years;
- to persons who are hypersensitive to the components of the drug.
With special care, "Votrient" follows the following categories of patients:
- with mild to moderate hepatic impairment;
- with thrombosis or other cardiovascular diseases;
- with gastrointestinal diseases.
In addition, patients who have thyroid problems need to monitor the functional state of the body when taking the described drug.
Before carrying out any kind of surgical intervention, the drug "Votrient" should be stopped in a week, since the main active substance affects the speed of wound healing.
Interaction with other drugs
"Votrient" is not used in conjunction with other antitumor drugs( such as "Lapatinib", "Pemetrexed", etc.).